# Xtant Medical Holdings, Inc. (XTNT)

> Source: Nexqual · https://nexqual.com/XTNT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Xtant Medical Holdings, Inc. (XTNT), nexqual.com/XTNT" · informational, not investment advice.

**Price:** USD 0.3 (-4.93% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.32 · day 0.3–0.33 · 52w 0.27–0.95 · market cap $42.5M · ASE

## Key facts
- Analysts: Buy (mean 1.67 on a 1–5 scale) (3 analysts), mean target USD 1.03 (range 0.6–1.5).
- Total return with dividends: 1Y -57.8% vs S&P 500 +18.1%; 5Y -72.7% vs S&P 500 +85.1%.
- Next earnings: 2026-11-10, EPS estimate USD -0.02, revenue estimate $25.5M.

## Analysts
Consensus Buy (mean 1.67 on a 1–5 scale), 3 analysts; mean target USD 1.03 (low 0.6, high 1.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-02 | LUCID CAPITAL MARKETS | Initiated | Buy | $1 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -57.8% | -72.7% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -57.9% | -22.8% |
| Volatility (annualized) | 67.2% | 67.3% |
| Max drawdown | -67.4% (Oct 2025→Oct 2026) | -77.3% (Aug 2023→Oct 2026) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/XTNT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt